GLP-1 medicines, mostly acylated peptides like semaglutide and liraglutide, have pleiotropic effects beyond weight and ...

Objective—Glucagon-like peptide 1 (GLP-1) exerts beneficial antidiabetic actions via effects on pancreatic β- and α-cells. Previous studies have focused on the improvements in β-cell function ...

A glucagon-like peptide-1 (GLP-1) drug appears to slow cognitive decline by protecting the brain, according to Phase 2b ...

Share on Pinterest An increasing number of people without diabetes are using GLP-1 agonist drugs for weight loss only. Image ...

No statistically significant differences between these values during stabilization, ischemia, or reperfusion were observed ( Table 1). As expected, ischemia produced bradycardia and hypotension ...

About The Study: Glucagon-like peptide receptor agonists (GLP-1RAs) were associated with lower risks of specific types of obesity-associated cancers compared with insulins or metformin in patients ...

GLP-1 agonist therapy did not affect the cardiorenal benefits of concurrent SGLT2 inhibitor use among patients with type 2 diabetes.

GLP-1s, or glucagon-like peptide-1 receptor agonists, are medications that help treat type 2 diabetes by mimicking the action ...

to examine potential applications of glucagon-like peptide-1 receptor (GLP-1R) agonists in central nervous system disorders, such as dementia, Parkinson’s disease, substance and alcohol use disorders, ...

Investigators at Cedars-Sinai and other institutions conducted a nationwide, population-based study to identify trends in the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs)-;prescription ...

An older drug in the same GLP-1 class as Ozempic, Wegovy, Mounjaro and Zepbound appeared to protect the brain from shrinking ...

WEIGHT-loss injections could help people quit smoking, a study suggests. It’s one of many benefits to have come out of the ...